Spots Global Cancer Trial Database for Early Palliative Care in Metastatic Lung Cancer in Northern France

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Early Palliative Care in Metastatic Lung Cancer in Northern France

Official Title: Impact of Early Palliative Care on Quality of Life and Survival of Patients With Non-small-cell Metastatic Lung Cancer in Northern France

Study ID: NCT02308865

Conditions

Lung Cancer Metastatic

Interventions

multi disciplinary palliative care monthly consultations

Study Description

Brief Summary: Single-center, prospective, controlled, open-label, randomized, two parallel arms comparing early Palliative care versus Standard care in patients with non-small-cell metastatic lung cancer

Detailed Description: 144 patients will be included; 72 per arm. * "Standard" Control arm: patient supported by the onco-respiratory service. * Intervention arm: patients benefit from early palliative care in addition to standard onco-pneumologic care. The main criterion of judgment is the TOI score measured at 12 weeks. FACTL questionnaires, HADS and PHQ-9 will be filled out before randomization , at 12 weeks and 21 weeks